Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease
and the leading cause of cancer mortality in women. Advances in molecular technologies …

Ductal carcinoma in situ (DCIS) represents pre-invasive breast carcinoma. In untreated
cases, 25–60% DCIS progress to invasive ductal carcinoma (IDC). The challenge lies in …

Background Although mastectomy is the standard treatment modality for breast cancer
patients in Ethiopia, our previous study revealed that one in five patients do not receive the …

Purpose This study was designed to:(1) characterize longitudinal patient-reported outcomes
(PROs) between breast cancer patients undergoing lumpectomy and mastectomy and (2) …

Background Deciding to have a mastectomy can be challenging for women. An
understanding of the decision-making experience related to mastectomy would contribute to …

Background Financial toxicity (FT) can lead to decreased quality of life and poor treatment
outcomes. However, there is limited published data on the extent to which the various …

Purpose The purpose of this study was to explore women's experiences with healthcare
providers previous to a flat closure after breast cancer. Methods Data was collected using …

Background Despite robust evidence confirming equivalent survival rates and better
cosmetic outcomes with breast-conserving surgery (BCS) and radiotherapy compared to …

As rates of total mastectomy rise, the relationships between surgery modality with domains
of health-related quality of life is not well understood. This study reports differences in …

Importance Guiding treatment decisions for women with ductal carcinoma in situ (DCIS)
requires understanding patient preferences and the influence of preoperative magnetic …